Excluding interest, depreciation and stock-based compensation on a non-GAAP basis, the Company had net income of $203,698 for the first quarter of 2009 compared to $338,310 for the first quarter of 2008. The non-GAAP net income (loss) is reconciled to comparable GAAP net income (loss) in the table entitled “Non-GAAP Calculation of Net Income.”
“Our 1% revenue increase does not reflect the fact that our new orders increased 17% in the first quarter of 2009 compared to the first quarter of 2008. By comparison, our first quarter of 2008 benefitted from a significantly larger beginning backlog as well as a one-time gain from a patent sale,” said Ron Bissinger, chief executive officer of Alpha Innotech.
Recent Highlights
Launched SpectraPlex, a multicolor fluorescent Western blotting kit optimized for use on the company’s FluorChem Q imager
Added sales personnel in China and India to continue building revenue-generating capabilities in the rapidly growing Asia region
Launched a portfolio of new service products allowing customers to choose from a variety of service and support options.
Alpha Innotech manufactures and sells analytical laboratory instruments, software and consumables used in life science research laboratories for the study of nucleic acids, proteins and cells.
